Sutton Wealth Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,473
| Closed | -$27.5K | – | 953 |
|
|
2022
Q4 | $27.5K | Sell |
3,473
-61
| -2% | -$483 | 0.01% | 577 |
|
|
2022
Q3 | $34K | Sell |
3,534
-22
| -0.6% | -$211 | 0.01% | 482 |
|
|
2022
Q2 | $25.7K | Buy |
3,556
+2,259
| +174% | +$16.4K | 0.01% | 586 |
|
|
2022
Q1 | $16.7K | Buy |
1,297
+281
| +28% | +$3.63K | 0.01% | 771 |
|
|
2021
Q4 | $16.2K | Buy |
1,016
+491
| +94% | +$7.84K | 0.01% | 772 |
|
|
2021
Q3 | $8.44K | Sell |
525
-76
| -13% | -$1.22K | ﹤0.01% | 963 |
|
|
2021
Q2 | $8.31K | Sell |
601
-51
| -8% | -$705 | ﹤0.01% | 963 |
|
|
2021
Q1 | $9.53K | Buy |
652
+110
| +20% | +$1.61K | ﹤0.01% | 893 |
|
|
2020
Q4 | $9.42K | Sell |
542
-268
| -33% | -$4.66K | ﹤0.01% | 830 |
|
|
2020
Q3 | $14.9K | Buy |
810
+268
| +49% | +$4.92K | 0.01% | 628 |
|
|
2020
Q2 | $9.68K | Buy |
+542
| New | +$9.68K | 0.01% | 713 |
|